In adults with type 2 diabetes, liraglutide 1.2 mg per day reduced systolic blood pressure more than placebo.
In plain wordsIn adults with type 2 diabetes, liraglutide 1.2 mg per day lowered systolic blood pressure more than placebo.
- Peptide
- Liraglutide
- Outcome
- DecreaseSystolic blood pressure change
- Study
n: not reported in source
- Comparator
- Placebo
- Outcome group
- Blood pressure · Cardiovascular
- Studied dose
- 1.2 mg per dayAs given in this study (human).
Measurements
- SBP mean difference
- −5.6 mmHg
- vs placebo, 1.2 mg
Source sentences
In the 1.2 mg-treated group, liraglutide treatment reduced SBP compared with placebo and glimepiride treatment, with mean differences of -5.60 and -2.38 mmHg, and 95% CIs of -5.84 to -5.36, p < 0.00001 and -4.75 to -0.01, p = 0.05, respectively.
1 context sentence(design, population, supporting numbers)
We searched the major databases for published or unpublished RCTs that had been performed in patients with T2DM and compared the effects of exenatide and liraglutide to those of other common drugs used to treat T2DM.